Advances in Gonorrhea

Gonorrhoea or gonorrhea, colloquially known as the clap, is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. Infection may involve the genitals, mouth, or rectum. Infected men may experience pain or burning with urination, discharge from the penis, or testicular pain. Infected women may experience burning with urination, vaginal discharge, vaginal bleeding between periods, or pelvic pain. Complications in women include pelvic inflammatory disease and in men include inflammation of the epididymis. Many of those infected, however, have no symptoms. If untreated, gonorrhea can spread to joints or heart valves. Gonorrhea is spread through sexual contact with an infected person. This includes oral, anal, and vaginal sex. It can also spread from a mother to a child during birth. Diagnosis is by testing the urine, urethra in males, or cervix in females. Testing all women who are sexually active and less than 25 years of age each year as well as those with new sexual partners is recommended; the same recommendation applies in men who have sex with men (MSM). Gonorrhea can be prevented with the use of condoms, having sex with only one person who is uninfected, and by not having sex. Treatment is usually with ceftriaxone by injection and azithromycin by mouth. Resistance has developed to many previously used antibiotics and higher doses of ceftriaxone are occasionally required. Retesting is recommended three months after treatment. Sexual partners from the last two months should also be treated. Gonorrhea affects about 0.8% of women and 0.6% of men. An estimated 33 to 106 million new cases occur each year, out of the 498 million new cases of curable STI – which also includes syphilis, chlamydia, and trichomoniasis. Infections in women most commonly occur when they are young adults. In 2015, it caused about 700 deaths. Descriptions of the disease date back to before the Common Era within the Hebrew Bible/Old Testament (Leviticus 15:2–3). The current name was first used by the Greek physician Galen before AD 200 who referred to it as "an unwanted discharge of semen".

In the present book, fourteen typical literatures about Gonorrhea published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on Gonorrhea. We hope this book can demonstrate advances in Gonorrhea as well as give references to the researchers, students and other related people.

Sample Chapter(s)
Preface (173 KB)
Components of the Book:
  • Chapter 1
    Optimal Control Dynamics of Gonorrhea in a Structured Population
  • Chapter 2
    Treatment of Bacterial Sexually Transmitted Infections in Europe: Gonorrhoea, Mycoplasma Genitalium, and Syphilis
  • Chapter 3
    At-Home Self-Collection of Urine or Vaginal Samples for Gonorrhea and Chlamydia Screening Among Young People Who Were Assigned Female at Birth
  • Chapter 4
    Resistance-minimising Strategies for Introducing a Novel Antibiotic for Gonorrhoea Treatment: a Mathematical Modelling Study
  • Chapter 5
    Kissing, Fellatio, and Analingus as Risk Factors for Oropharyngeal Gonorrhoea in Men Who Have Sex with Men: A Cross-sectional Study
  • Chapter 6
    Public Health Impact and Cost-effectiveness of Gonorrhoea Vaccination: an Integrated Transmission-dynamic Health-economic Modelling Analysis
  • Chapter 7
    Mathematical Analysis of a Model for Chlamydia and Gonorrhea Codynamics with Optimal Control
  • Chapter 8
    Impact of the COVID-19 Pandemic on Chlamydia and Gonorrhea Screening in the U.S.
  • Chapter 9
    Ensuring Equity with Pre-clinical Planning for Chlamydia Vaccines
  • Chapter 10
    Chlamydia Trachomatis from Australian Aboriginal People with Trachoma are Polyphyletic Composed of Multiple Distinctive Lineages
  • Chapter 11
    Replication-dependent Size Reduction Precedes Differentiation in Chlamydia Trachomatis
  • Chapter 12
    Chlamydia Infection Depends on a Functional MDM2-p53 Axis
  • Chapter 13
    Chlamydia Trachomatis Serovars in Urogenital and Ocular Samples Collected 2014–2017 from Austrian Patients
  • Chapter 14
    Genetic and Phenotypic Analysis of the Pathogenic Potential of Two Novel Chlamydia Gallinacea Strains Compared to Chlamydia Psittaci
Readership: Students, academics, teachers and other people attending or interested in Gonorrhea .
Lorenzo Giacani
Department of Global Health, University of Washington, Seattle, WA, United States of America

Catriona S. Bradshaw
Central Clinical School, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia

E. Reichert
Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts, USA

R. Yaesoubi
Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut, USA

J.A. Salomon
Department of Health Policy, Stanford University School of Medicine, Stanford, CA, USA

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top